Big Upside Potential In Big Pharma
The research team at Bank of America Merrill Lynch sees big upside potential for Big Pharma in the remaining months of 2018. Here are some… Read More »Big Upside Potential In Big Pharma
The research team at Bank of America Merrill Lynch sees big upside potential for Big Pharma in the remaining months of 2018. Here are some… Read More »Big Upside Potential In Big Pharma
With the global market for wearable medical devices projected to surpass $12 billion by 2021, healthcare is poised to be “the next most happening growth… Read More »Wearables: Tech Stocks’ Next Growth Frontier
Investors seeking an early-mover advantage in the legal cannabis market may be best served by taking a position in a company with all the hallmarks… Read More »A Legal Cannabis Market Leader For Early Movers
Move over, cannabis growers. There’s more than one way to gain exposure to the marijuana industry. In fact, here are nine different ways – and… Read More »Marijuana Investing, In All Its Forms
With an estimated $57 billion global marijuana market up for grabs, this small investment company’s “first mover approach” all over the world gives it a… Read More »First-Mover Advantage In The Coming World Of Weed
In May, Canopy Growth became the first marijuana stock to trade on the NYSE. Here, the company’s CEO (the self-proclaimed “world’s biggest legal-weed dealer”) shares… Read More »Marijuana Musings From The “World’s Biggest Legal-Weed Dealer”
A recent study found that more than half of millennial women have money to invest but, out of fear, are not doing so. Here’s the… Read More »The Cost Of Fear
This under-the-radar cannabis company is taking a different approach from most – choosing to be the big fish in small ponds. Here’s why its strategy… Read More »An “Unassuming” Cannabis Company With A “Big Fish” Strategy
Do companies led by women outperform the market? Here’s what a pair of researchers found when they examined the data – and the most important… Read More »The Facts About Female-Led Firms
Among small-cap stocks – which have been robustly outperforming their large-cap counterparts this year – healthcare small-caps have been the most impressive performers. Which healthcare… Read More »Bargain Hunting In Declining Health